Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Pharmaceutical Discount Contracts In Accordance With Section 130A (8C) Sgb V From 01.08.2025 On Various Active Substances In The Context Of An Open House Process
Deadline - May 21, 2027
GT reference number - 109648302
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 109648302
Document Type - Tender Notices
Description - Description: Scope of procurementShort descriptionThe subject of this publication is the conclusion of non-exclusive discount contracts in accordance with Section 130a (8c) SGB V for parenteral preparations made in pharmacies from finished medicinal products in oncology for direct medical use in patients for the regions of North Rhine-Westphalia, Hamburg and Schleswig-Holstein. The non-exclusive discount agreements are each offered for regional ose 1 (North Rhine-Westphalia), 2 (Hamburg), 3 (Schleswig-Holstein) for the following active ingredients:Bevacizumab (L01FG01)Eribulin (L01XX41)Rituximab (L01fa01)Trastuzumab (L01FD01)The earliest start of the contract is 01.08.2025. Based on this, th
Gt Ref Id - 109648302
Deadline - May 21, 2027
Similar Tenders :
Summary:
|
Summary:
|
Summary:
|
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database